COMPANY
HemoGenix
- Type
- CRO
- Services
- Toxicology / safety, In vivo pharmacology
NIH awards 4
- NIH contract (government contract; not a grant and not an investment round) 273200900143P-1-0-1 FY2009: $154,000 awarded for that fiscal year; activity N02 (OTHER_NIH); PI HALL, KAREN; recipient as written: HEMOGENIX, INC., COLORADO SPRINGS, CO. NTP HIGH THROU source ↗
- NIH award 5R44CA093244-03 FY2004: $424,565 awarded for that fiscal year; activity R44 (SBIR); PI RICH, IVAN N; recipient as written: HEMOGENIX, INC., COLORADO SPRINGS, CO. An In Vitro Throughput Stem Cell Hemotoxicit source ↗
- NIH award 2R44CA093244-02 FY2003: $502,065 awarded for that fiscal year; activity R44 (SBIR); PI RICH, IVAN N; recipient as written: HEMOGENIX, INC., COLORADO SPRINGS, CO. An In Vitro Throughput Stem Cell Hemotoxicit source ↗
- NIH award 1R43CA093244-01 FY2001: $120,000 awarded for that fiscal year; activity R43 (SBIR); PI RICH, IVAN N; recipient as written: HEMOGENIX, INC., COLORADO SPRINGS, CO. AN IN VITRO HIGH THROUGHPUT STEM CELL HEMOTO source ↗